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AGING NEUROSCIENCE
targeted studies focused on single proteins [e.g., determination of 
SNARE binding domains assessed cleavage/deletion-mediated pro-
tein inactivation (Schiavo et al., 1993; Deak et al., 2006)] or families 
of proteins [e.g., demonstration of the impact of multiple synapsin 
isoform-knockouts on the synaptic vesicle cycle and cognitive func-
tion (Corradi et al., 2008)], these traditional approaches provide 
circumscribed insight into the complexities of the neuroproteome 
and its role in mediating various brain functions (e.g., learning and 
memory). This is due in part to low throughput and the require-
ment that the identities of specific proteins of interest be deter-
mined a priori for functional and targeted studies. Recent advances 
in proteomic technologies and their increasing implementation in 
neuroscience research present an opportunity to expand our exist-
ing understanding and provide a deeper insight into the molecular 
components of cognition. Using neuroproteomic approaches, we 
can also better characterize brain region-specific alterations that 
contribute to neural dysfunction and cognitive impairments with 
conditions ranging from normal aging to neurodegenerative dis-
eases. Of primary necessity is a detailed assessment of the effects 
of age on the neuroproteome and how they affect generalized cel-
lular functions such as energy production and cytoskeletal mainte-
nance, as well as neuron-specific functions including maintenance 
of vesicle trafficking, neurotransmitter release and reuptake, and 
synaptic remodeling. This is particularly true for the hippocampus, 
which is the primary brain structure implicated in spatial learn-
ing and memory, and which is profoundly affected by aging. This 
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Age-related cognitive decline is a common complication of aging 
that impacts a variety of brain functions including perceptual speed, 
inductive reasoning, and perhaps most disabling, hippocampus-
dependent spatial learning and memory (Hedden and Gabrieli, 
2004). Impairment of these functions reduces quality of life for aging 
individuals by diminishing the health-span and decreasing independ-
ence. Currently, an estimated 40% of the otherwise healthy popula-
tion over age 60 is affected by varying degrees of cognitive decline, 
which increases in prevalence and severity with co-morbid condi-
tions such as Type 2 diabetes, hypertension, and heart disease (Qiu 
et al., 2005; Panza et al., 2008; Dahle et al., 2009; Crowe et al., 2010; 
Ding et al., 2010; Okonkwo et al., 2010). As the quality and avail-
ability of health care in developed countries continue to improve, the 
percentage of aged individuals in the population is expected to con-
tinue to rise. For example, as of the 2000 U.S. census, approximately 
12% of the U.S. population was over age 60 (CensusScope, 2010), 
and population projections suggest that by 2050, this age group will 
account for more than one in five persons in the total U.S. population 
(Shrestha, 2006). The prevalence of age-related health conditions is 
expected to rise concomitantly with our increasing lifespan, and as 
such, a greater emphasis must be placed on understanding, prevent-
ing, and treating complications like cognitive decline.
Our knowledge of the molecular basis of brain function in gen-
eral, and neurotransmission specifically, has grown exponentially 
over the last two decades. Although much has been learned from 
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hippocampus with aging and cognitive decline and not detail the 
technical aspects of various proteomic methods which have been 
discussed in several previous reviews (Freeman and Hemby, 2004; 
Drabik et al., 2007; Friedman et al., 2009; Lull et al., 2010). Aspects 
of the neuroproteome that remain to be examined and future direc-
tions for the field will also be discussed in the context of known 
physiological alterations in hippocampal function with aging and 
cognitive decline.
Hippocampal function is altered witH aging and 
cognitive decline
The hippocampus is the primary mediator of spatial learning and 
memory, which is impaired in aging subjects experiencing cogni-
tive decline (Hedden and Gabrieli, 2004). Loss of hippocampus-
dependent spatial cognition reduces independence, mobility, and 
activity, and diminishes health status and quality of life. Numerous 
anatomical and physiological alterations have been characterized 
in the hippocampus with aging that may contribute to cognitive 
decline, including decreased hippocampal volume without gross 
neuronal loss, vascular rarefaction, decreased trophic support, 
increased oxidative stress and inflammation, decreased metabolism 
and glucose utilization, dysregulation of protein synthesis, folding, 
and accumulation, and impaired neurotransmitter synthesis and 
release (Sonntag et al., 1999; Calabrese et al., 2004; Paz Gavilan et 
al., 2006; Poon et al., 2006; Rowe et al., 2007; Freeman et al., 2009; 
Pawlowski et al., 2009; Erickson et al., 2010). Broad dysregulation 
of these processes with increasing age impacts hippocampal func-
tion in a variety of ways ranging from cytoprotection to energy 
biogenesis to intracellular trafficking of proteins and organelles.
At the most basic level, cognitive function is a reflection of 
neuronal activity and synaptic signaling. Synaptic dysfunction, 
indicated by altered hippocampal neurochemistry, morphology, 
and electrophysiology (e.g., LTP, LTD, PPF), is also associated with 
aging and cognitive decline (Boric et al., 2008; Sierra-Mercado et 
al., 2008; Gureviciene et al., 2009). Electrophysiological correlates 
of hippocampal function are disrupted with aging and learning 
impairment, and are consistent with unstable encoding of spatial 
representations (Barnes et al., 1997; Rosenzweig and Barnes, 2003; 
Wilson et al., 2003; Kumar et al., 2007). This instability manifests 
in resistance to LTP induction, facilitation of LTD, and aberrant 
spatiotemporal activation of ensemble networks. These character-
istics may be related to atypical synapse morphology, decreased 
neurotransmitter synthesis and receptor signaling, and changes 
in neuronal protein and gene expression occurring with increas-
ing age (Burke and Barnes, 2006; Shi et al., 2007; Liu et al., 2008). 
Additionally, age-related cognitive decline is associated with a pref-
erential loss of functional high-efficiency synapses (i.e., multiple 
spine bouton and perforated synapses) implicated in spatial learn-
ing and memory formation (Geinisman et al., 1986; Shi et al., 2005; 
Burke and Barnes, 2006). The molecular processes underlying these 
changes have been partially identified, but remain to be compre-
hensively investigated. Further, identification of both the specific 
proteins and the broader pathways and processes dysregulated spe-
cifically with cognitive decline is needed to delineate the general 
effects of aging from those implicated in decreasing cognitive abil-
ity. A full understanding of the hippocampal neuroproteome with 
aging and age-related cognitive deficits will be an important first 
step in development of therapies that target cognition-associated 
alterations to prevent or reverse cognitive decline.
defining tHe Hippocampal neuroproteome
Given the complexities of obtaining and analyzing human brain 
tissue, the well-described similarities between human and rodent 
neurophysiology, and the availability and practicality of rodent 
model organisms, rat and mouse models are the most common 
mammalian model systems in neuroscience research. As such, 
initial neuroproteomic studies focused on defining components 
of the whole-brain rodent proteome (Fountoulakis et al., 1999). 
Although profiling of the whole-brain proteome has yielded useful 
information, specific examination of the hippocampus is important 
in elucidating the molecular mechanisms underlying the forma-
tion and retrieval of spatial memory. A key early assessment of 
the human hippocampal proteome was reported in 2000 by Edgar 
et al. (1999), who applied 2DE protein separation, liquid chroma-
tography–coupled mass spectrometry (LC–MS) and N-terminal 
sequencing to profile protein species present in the hippocampus 
of one middle aged female. This work identified nearly seventy 
proteins, including numerous cytoskeletal and mitochondrial 
elements. Subsequent work extended these findings with higher-
throughput profiling of the hippocampal proteome in postmortem 
tissue isolated from adult males and females (mean age 61 years; 
Yang et al., 2004). This approach combined 2DE protein separa-
tion with tandem mass spectrometry (MS/MS) that yields more 
conclusive protein identifications. More than 160 unique proteins 
were identified, the majority of which are components of metabolic 
pathways comprising glycolysis and the citric acid cycle. Assessment 
of the rat hippocampus (Fountoulakis et al., 2005) further added 
to known components of the hippocampal neuroproteome and, 
in agreement with proteomic profiles of the human hippocampus 
(Edgar et al., 1999; Yang et al., 2004), cytosolic proteins and mito-
chondrial enzymes comprised approximately 50% of the identified 
proteins. These proteins are highly abundant and tend to represent 
the majority of proteins identified in unfractionated neural tis-
sue. Together these, and other, early profiling studies provided a 
groundwork for future neuroproteomic studies by demonstrating 
the utility of proteomic technologies in characterizing the diversity 
of proteins expressed in the hippocampus. A challenge common 
to these reports is the limited detection of low-abundance and 
subcellular compartment-specific neuronal proteins (e.g., regula-
tors of the synaptic vesicle cycle), which are frequently masked by 
highly expressed proteins (e.g., metabolic enzymes and cytoskeletal 
components). This challenge has been partially addressed through 
the development of approaches that increase the coverage (i.e., the 
diversity of proteins simultaneously examined) and the sensitiv-
ity (i.e., detection of low-abundance proteins) of neuroproteomic 
assessments.
An effective approach to increasing the insight provided by neu-
roproteomic studies is examination of hippocampal synaptosome, 
synaptic plasma membrane, and synaptic lipid raft preparations 
(Bai and Witzmann, 2007; Jiang et al., 2008; Fernandez et al., 2009; 
Wu et al., 2010). These subcellular fractionation techniques enrich 
for synaptic proteins typically masked by highly abundant meta-
bolic and cytoskeletal proteins. The value of sample fractionation 
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abundance, modification, and localization across the lifespan, as 
described below and summarized in Table 1, has dramatically 
increased our understanding of brain aging. Further, these studies 
have also identified molecular correlates, and potential molecular 
mechanisms, of deficits of hippocampal function.
cHaracterization of tHe Hippocampal proteome 
witH aging
The Human Proteome Organization initiated the Brain Pilot 
Project in 2003 with the goal of characterizing the neuropro-
teomes of humans and rodent models throughout the lifespan. 
Quantitative proteomic analyses of the aging hippocampus have 
identified numerous proteins altered in expression with increas-
ing age and provide insight into processes and signaling pathways 
implicated in brain aging. While initial reports focused on quantita-
tive comparisons of the whole-brain proteome between neonatal 
and adult rodents, they are informative of the temporal regulation 
of protein expression in neural tissue. For example, in agreement 
with known increases in glucose utilization in the adult brain, this 
study also identified upregulation metabolic enzymes including 
creatine kinase, alpha enolase, and triosephosphate dehydrogenase 
in adult (8 weeks) compared to neonatal (7 days) mice (Carrette et 
al., 2006). Similar work compared whole mouse brain proteomes 
of these age groups and an additional embryonic group (embry-
onic day 16), using two-dimensional difference gel electrophoresis 
(2-DIGE; Focking et al., 2006). The 2-DIGE technology fluores-
cently labels cysteine residues, allowing multiplexing of up to three 
protein samples on each gel. Each 2-DIGE gel typically combines 
two experimental samples and a normalization pool (containing 
equal protein from all study samples) used to standardize pro-
tein spot quantitation between gels. This screen enabled a broader 
assessment of temporal regulation of protein expression, and iden-
tified a variety of proteins peaking at different ages. For example, 
fascin, alpha-fetoprotein, tubulin isoforms, and actin were most 
highly expressed in embryonic brain, while neonatal brain most 
highly expressed fatty acid binding protein, syntaxin, peroxiredoxin 
2, and dihydropyrimidinase-related protein-3. Metabolic proteins 
involved in ATP generation and glucose bioenergetics were most 
highly expressed in the adult brain, again concurring with the 
higher rate of glucose metabolism in adulthood. These studies, 
although focused on developmental stages rather than the aging 
process, provided valuable data regarding neuroproteomic regula-
tion with increasing age.
In 2008, Yang et al. (2008) published a laudable effort to profile 
the rodent brain proteome over a broad time-course of natural 
aging by comparing protein isolated from whole brains of neo-
natal (4 days), young adult (3 months), mature adult (6 months), 
middle aged (12 months) and aged (15 months) male Kunming 
mice using 2DE and semi-quantitative densitometry. This analysis 
identified decreased expression of numerous protein regulators of 
protein quality (proteasome subunits, ubiquitin carboxyl-terminal 
esterase L3, calreticulin) and synaptic function (calbindin, amphi-
physin, valosin-containing protein), among others, with increasing 
age. Proteins that increased with aging were mainly enzymes that 
mediate energy production and oxidative stress. A key feature of 
this report is the demonstration of multiple protein expression 
is demonstrated by a 2005 report describing mass spectrometric 
profiling of hippocampal plasma membrane fractions (Nielsen et 
al., 2005). This study used both standard LC–MS/MS and higher 
accuracy Fourier transform ion cyclotron resonance MS (FT-MS), 
which resolves ion mass-to-charge ratios by their rotational fre-
quency in a strong magnetic field as they pass by the detection 
plates. This combinatorial approach described led to identification 
of numerous species, the majority of which, unlike whole-tissue 
profiling, were annotated as membrane proteins. Of these, only a 
small percentage originated from mitochondrial or endoplasmic 
reticulum membranes, and compared to whole hippocampus, 
mitochondrial content was nearly depleted which allowed identi-
fication of proteins previously not detected in proteomic analyses. 
Many integral and plasma membrane proteins identified were hip-
pocampally expressed subunits of GABA and glutamate receptors, 
as well as voltage-gated potassium, sodium, and calcium channels. 
Proteomic characterization of hippocampal postsynaptic densi-
ties by LC–MS/MS profiling of affinity-purified, PSD95-associated 
proteins (Dosemeci et al., 2006) has also identified a number of 
synaptic proteins, including maguin, PSD93, Shank 1, and Shank 
3, and signaling molecules such as CaMKII, SynGAP, and protein 
kinase C. Presynaptic “contaminants” (e.g., piccolo, bassoon, syn-
apsin 1, and synapsin 2) and proteins associated with neuronal 
extracellular matrix (e.g., tenascin-R, proteoglycan-link protein, 
fibronectin) were also identified, perhaps complicating analysis 
of PSD fractions per se but also increasing our awareness of the 
complexity of the hippocampal neuroproteome. These reports 
contribute valuable understanding of the composition of hip-
pocampal subproteomes, and demonstrates that pairing fractiona-
tion with proteomic approaches increases sensitivity of proteomic 
technologies to evaluate significant populations of low-abundance 
proteins in small amounts of neurologically derived starting mate-
rial. Similar approaches have been broadly implemented in neu-
roscience research, and are seeing increasing usage in the aging 
research field.
The neuroproteomic studies discussed thus far have been 
broad-based profiling studies seeking to determine the identity 
and diversity of proteins present in hippocampal tissue. Although 
characterization of the hippocampal neuroproteome is important 
to our understanding of potential mechanisms of hippocampal 
function, integration of methods capable of quantitative compari-
sons of proteomic composition in health and disease are also neces-
sary. Multiple methods of proteome quantitation exist, each with 
its strengths and limitations (Chen et al., 2007b; Wiese et al., 2007). 
One example of the capabilities of quantitative neuroproteomic 
assessment is the demonstration of enriched synaptic plasticity-
associated protein (e.g., PSD-95, CaMKIIα, homer 1, NMDA, and 
AMPA receptors) content in hippocampal postsynaptic density 
preparations compared to those from other brain regions (e.g., 
cerebellum; Trinidad et al., 2008). With the advances made by the 
studies described above, it is clear that proteomic approaches are 
highly useful and are becoming more routinely implemented in 
neuroscience research. The ability to quantitatively characterize the 
hippocampal neuroproteome and subproteomes (either through 
anatomical fractionation or proteome enrichment) provides the 
aging research field with a powerful tool for investigating differen-
tial protein expression with aging and age-related impairment of 
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rats exhibited increased expression of aconitase 2, dihydrolipoam-
ide dehydrogenase, neuroprotective peptide H3, dynamin-like pro-
tein 1, and eukaryotic initiation factor 5a. These findings suggest a 
diverse mode of action of caloric restriction via potential processes 
ranging from metabolism and protein synthesis to neuronal integ-
rity. Unfortunately, younger age groups were not included in this 
analysis, so it is not possible to conclude that caloric restriction 
produces a “less aged” phenotype, or whether its putative benefi-
cial effects are diminished in aged rats compared to their younger 
counterparts.
The effects of aging on the proteomic composition of hippocam-
pal synapses (i.e., the hippocampal synaptoproteome) have also 
been described. Using an approach combining synaptosome isola-
tion from young (9 weeks) and aged (30 months) female Fischer 
rats with 2-DIGE proteomic quantitation and MS protein identifi-
cation, Sato et al. (2005) identified a number of proteins regulated 
with aging. Proteins decreased in aged rats included T-complex 1, 
collapsin response mediator protein 4, hsp60, coronin 1A, and sev-
eral metabolic enzymes, while proteins increased with age included 
GFAP, SNAP25, septin 2, and actin. Evaluation of female rats is less 
common than males for logistical purposes, and so the proteomic 
profiles generated here are beneficial for intersex comparisons of 
neuroproteomic composition and assessment of potential differen-
tial susceptibility to age-related processes in males versus females. 
Although the focus on lower abundance, synapse-specific proteins 
is often more valuable than approaches using unfractionated tissue, 
the small number of proteins identified in this study limits broader 
bioinformatic analysis and interpretation.
Our laboratory recently reported the results of an investiga-
tion of the hippocampal synaptoproteome that included male 
Fischer 344 × Brown Norway (F1) hybrid rats aged 3 (young-
adult), 12 (adult), and 26 months (aged; VanGuilder et al., 2010). 
These rats are genetically identical, and exhibit the long lifespan of 
the Fischer 344 rat combined with the health-span of the Brown 
Norway, which minimizes potential age-related pathologies that 
can confound behavioral analyses. 2-DIGE quantitation of hip-
pocampal synaptosomes determined differential expression of 
more than 250 proteins between the three age groups. Age-regulated 
proteins, as well as a large selection of stably expressed proteins, 
were identified by MS/MS. A subset of proteins observed in this 
work confirms previous findings of the Sato et al. (2005) investiga-
tion of hippocampal synaptosomes isolated from young-adult and 
aged female Fischer rats. Commonalities include decreased expres-
sion of isocitrate dehydrogenase, creatine kinase B, and protein 
disulfide isomerase, and increased expression of GFAP in aged rats, 
underscoring disruptions of glucose and protein metabolism with 
aging. Bioinformatic analysis of proteins regulated with increas-
ing age identified a network of “nervous system function” pro-
teins that was significantly over-represented among differentially 
expressed proteins. The majority of neurotransmission-related 
changes in synaptosomal protein expression occurred between 
adulthood and advanced age, and included downregulation of com-
monly identified structural proteins (F-, gamma- and beta-actin, 
numerous tubulin isoforms, internexin) as well as lower-abun-
dance synaptic proteins (synapsin 1, syndapin 1, clathrin, tropo-
modulin 2, amphiphysin, syntaxin binding protein). Immunoblot 
patterns across the lifespan. These changes included consistent 
increases (transketolase, mitochondrial creatine kinase) and con-
sistent decreases (proteasome subunits alpha type 3, alpha type 
6, 26S non-ATPase 14), as well as biphasic patterns in which pro-
teins increased in expression through adulthood but decreased with 
aging (amphiphysin, dynamin, voltage-dependent anion channel 
1). As is typical in proteomic analyses of unfractionated neural 
tissue, a high percentage of identified proteins represented abun-
dant nuclear (30%) and mitochondrial (20%) species, underscor-
ing the value of enrichment approaches to increase detection of 
less-abundant proteins.
These works assessed the proteomic composition of the entire 
brain rather than its functionally distinct structures, and focused 
on relatively young ages. To assess hippocampus-specific alterations 
with advanced age, the Youdim laboratory performed neuroprot-
eomic profiling of female Wistar rats aged 8 and 27 months by 2DE 
with MS protein identification (Weinreb et al., 2007). Significantly 
higher hippocampal expression of neurofilament light chain, fer-
ritin heavy polypeptide 1, T-complex protein 1, profilin 1, and 
isocitrate dehydrogenase 2α were evident in aged rats compared 
to adults. Expression of protein translation elongation factor Tu, 
phosphatidylethanolamine binding protein (PEBP), astrocytic 
phosphoprotein PEA15, peroxiredoxin 2, and the Va and Vb subu-
nits of cytochrome c oxidase was decreased with aging. Differential 
expression of members of proposed classes of proteins represented 
by proteomic alterations [i.e., neurodegenerative disease (ferritin), 
binding proteins/chaperones (profilin 1), and metabolism/oxida-
tion (peroxiredoxin 2)] was confirmed by targeted immunoblot-
ting, which is becoming a routine component of neuroproteomic 
investigations. Several age-regulated proteins identified by this work 
have been associated with age-related decrements of hippocampus-
dependent learning and memory and increased oxidative stress, 
suggesting a potential mechanistic role for dysregulation of these 
proteins in functional deficits with hippocampal aging (Chen et 
al., 2003; Feldmann et al., 2008; Ramos et al., 2009; Quintana and 
Gutierrez, 2010).
In addition to studying the expression of proteins, it is also 
important to identify changes in protein post-translational modi-
fications as they play integral roles not only in protein localization 
and function, but also in the pathogenesis of a variety of conditions 
including age-related disease. In a study of hippocampal protein 
oxidation in aged male Wistar rats, neuroproteomic approaches 
were implemented to quantify carbonyl, 4-hydroxynonenal (HNE), 
and 3-nitrotyrosine (3-NT) protein adducts and to assess the effects 
of caloric restriction on protein modification by these reactive spe-
cies (Poon et al., 2006). Rats either had free access to food or were 
calorically restricted to approximately 60% of control intake from 
12 months of age, with food available every two days. After rats 
reached 28 months of age the hippocampal neuroproteome was 
quantitatively characterized by 2DE with MS identification of dif-
ferentially expressed/modified proteins. Protein carbonylation and 
nitrosylation was determined by two-dimensional immunoblot-
ting (often referred to as “far-western” blotting) while carbonyl, 
3-NT, and HNE levels were determined by slot blot. These analyses 
determined that caloric restriction of aged rats reduces bulk hip-
pocampal HNE and 3-NT levels, and also decreases nitrosylation of 
malate dehydrogenase, 14-3-3 zeta, and phosphoglycerate kinase 1. 
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lated with increasing age and learning and memory. The iden-
tification of these differentially expressed proteins provides the 
opportunity for interventional studies seeking to normalize glu-
cose metabolism and restore energy production in the aging hip-
pocampus. Similarly, impaired protein processing is associated 
with hippocampal aging. This is commonly evident in the accu-
mulation of protein aggregates and increased cellular stress caused 
by oxidized and misfolded proteins (Squier, 2001; Paz Gavilan et 
al., 2006). Age-related dysregulation of proteins driving protein 
folding, trafficking and degradation has been characterized by 
neuroproteomic studies of the unfractionated hippocampus as 
well as of hippocampal synapses. Decreased expression of proteins 
with chaperone and folding functions (e.g., heat shock proteins, 
T-complex protein 1, protein disulfide isomerase A3, protein 
phosphatase 1) as well as components of the protein degradation 
process (proteasome alpha subunits 1, 3, and 6, 26S proteasome 
non-ATPase regulatory subunit 14, ubiquitin C-terminal ester-
ase L3, pyromycin-sensitive aminopeptidase) indicates a loss of 
protein quality regulation with aging that may contribute to the 
observed buildup of cytoskeletal proteins (e.g., increased neuro-
filament light chain and tubulin) with increasing age. Likewise, 
impairment of protein folding and degradation pathways may 
contribute to accumulation of misfolded and oxidized proteins, 
which are implicated in inflammation- and stress-response with 
aging (Keller et al., 2002).
Oxidative stress is typically associated with mitochondrial 
dysfunction and/or modification of proteins by reactive adducts. 
Neuroproteomic assessment of the aged hippocampus has revealed 
decreased expression of anti-oxidant proteins (e.g., peroxiredoxin 
2 and 6) as well as oxido-reductase enzymes (cytochrome c oxidase 
subunits and ubiquinol-cytochrome core protein 1), suggesting 
an impairment of regulated mitochondrial energy production. 
Aberrant coupling of electron transfer via decreased expression 
of these proteins may not only impair energy production, but 
also increase mitochondrial stress load. Likely downstream effects 
of this include increased hippocampal oxidative stress and sub-
sequent inflammation, both of which have been reported with 
normative aging as well as with age-related neurodegenerative 
diseases (Weinstock et al., 2009; Ownby, 2010). This is evident in 
upregulated expression of inflammation-response proteins GFAP 
and annexin A4 and decreased astrocytic phosphoprotein 15, an 
inhibitor of tumor necrosis factor receptor signaling in neuropro-
teomic studies of aging hippocampus. Together, dysregulation of 
these proteins suggests a mechanism of impaired anti-oxidant/anti-
inflammatory activity and increased oxidative stress and inflam-
mation response in the aged hippocampus.
Impaired hippocampal neuronal activity is a well-characterized 
effect of aging in humans, and often coincides with deficits of 
learning and memory (Daselaar et al., 2006; Dennis et al., 2008; 
Beeri et al., 2009). Age-related decrements in hippocampal activ-
ity and encoding of spatial field maps, demonstrated by ensemble 
recordings, also occur in aged rodents and correlate with impaired 
performance on behavioral tests of hippocampus-dependent spa-
tial learning and memory (Norris et al., 1996; Barnes et al., 1997; 
Wilson et al., 2003). Impaired synaptic plasticity (i.e., long-term 
potentiation, long-term depression, paired-pulse facilitation) and 
 confirmation of a  number of proteins with well-characterized roles 
in  neurotransmission  confirmed expression decreases (14-3-3 zeta 
and gamma, synapsin 1, dynamin 1) and increases (synapsin 2, 
hippocalcin) with increasing age. Based on these neuroproteomic 
findings, immunoblot analyses were extended to include addi-
tional neurotransmission-regulating proteins, and determined a 
significant effect of age on synaptic expression of synaptophysin, 
PSD95, and the SNARE proteins VAMP2, SNAP25, and syntaxin 
1, all of which decreased with increasing age. In total, 404 hip-
pocampal synaptosomal proteins were identified with high confi-
dence, contributing to our understanding of the complex proteomic 
composition of hippocampal synapses. The findings of this study 
suggest that expression of many proteins regulating hippocampal 
neurotransmission undergoes significant age-related alterations 
between adulthood and advanced age. The proteins affected are 
implicated in synaptic vesicle exocytosis and endocytosis, postsyn-
aptic receptor aggregation, and activity-dependent synaptic main-
tenance, which may decrease stimulus-induced neurotransmission 
and could potentially impact learning and memory functions in 
the aged hippocampus.
The studies described above have examined effects of aging on 
the whole-brain, hippocampal, and hippocampal synaptosomal 
neuroproteomes, and demonstrate not only the complexity of the 
neuroproteome but also the high degree of regulation that occurs 
with natural aging. A limitation of the aging neuroproteomics 
research field is a lack of standard rodent models, ages, and tech-
nological approaches. The existing reports of age-related regulation 
of the neuroproteome have utilized multiple strains of mice and 
rats, assessed both male and female, and included time points rang-
ing from embryonic and neonatal stages to advanced age, which 
limits direct comparison of these datasets. However, commonalities 
in processes regulated with aging have emerged from the findings 
of these studies.
common tHemes in neuroproteomic investigations 
of tHe aging Hippocampus
Neuroproteomic investigations of the aging hippocampus have 
identified specific protein species as well as protein pathways 
and signaling networks that are dysregulated with aging and 
age-related cognitive decline. Additionally, this research has pro-
vided mechanistic insight into broader processes known to be 
altered with aging (Figure 1). These processes include glucose 
metabolism, protein processing, oxidative stress and inflamma-
tion, and synaptic function. For example, metabolic disruption 
and decreased glucose utilization are reproducibly demonstrated 
in aging humans and animal models of human aging (Tack et al., 
1989; Sonntag et al., 2006; Kantarci et al., 2010). Quantitative 
assessments of the hippocampal proteome have revealed altered 
expression of numerous proteins that play both integral and 
regulatory roles in glycolysis and gluconeogenesis (e.g., enolase, 
aldolase, creatine kinase, lactate dehydrogenase, pyruvate kinase, 
phosphoglycerate mutase, isocitrate dehydrogenase, phosphof-
ructokinase). A subset of these proteins is necessary for the ATP-
generating stages of glucose metabolism, which converges with 
functional studies revealing decreased energy biogenesis in the 
aging brain. Interestingly, several of these proteins (e.g., alpha 
enolase) are differentially expressed with both aging and  cognitive 
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likely leads to aberrant hippocampal activity and ultimately, to 
cognitive symptoms.
tHe Hippocampal proteome witH learning and 
memory
Given that age-related decrements in cognitive function occur het-
erogeneously in both human and animal model populations, and 
that cognitive decline occurs on a background of aging-related 
proteomic alterations, studies pairing behavioral assessments of 
cognitive function with quantitative proteomic analyses at multi-
ple ages are needed. As the relationship between neurochemistry 
and behavior has moved to the forefront of neuroscience research, 
investigations of the effects of spatial learning and memory on the 
hippocampal proteome have been initiated (Table 1). The intro-
duction of additional complexities of study design must be taken 
into consideration in these investigations to maximize the utility 
of resultant data. In addition to the intricacies of the proteomic 
techniques, clearly described animal model and behavioral test-
ing methods are necessary; if these important details are lacking, 
deficits of synaptic transmission underlie these phenomena and 
have been reproducibly demonstrated in aged rodents compared to 
their younger counterparts (Norris et al., 1996; Boric et al., 2008; 
Sierra-Mercado et al., 2008; Gureviciene et al., 2009). Numerous 
neuroproteomic reports have identified decreased expression of 
proteins contributing to these processes with increasing age. For 
example, SNARE complex proteins (VAMP2, SNAP25, and syn-
taxin 1), vesicle-mobilizing proteins (synapsin 1, synaptophysin) 
and postsynaptic proteins (PSD95) are significantly decreased in 
hippocampal synapses of aged rats compared to mature adults, 
indicating a loss of effective neurotransmission-mediating machin-
ery. Likewise, components of the synaptic vesicle cycle (amphiphy-
sin, dynamin, septin, N-ethylmaleimide sensitive fusion protein) 
are decreased with age, which likely decreases vesicle recycling 
and synaptic efficacy. Mechanisms of cytoskeletal dynamics and 
neuronal signal transduction are also implicated in age-related hip-
pocampal dysfunction by neuroproteomic findings demonstrat-
ing altered expression of regulatory proteins including coronin, 
spectrin, profilin, collapsin response mediator proteins, PEBP, tro-
pomodulin, and syndapin, among others. Together, these results 
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Figure 1 | Cellular processes altered in the aging hippocampus. Integration of 
age-related neuroproteomic alterations in the hippocampus reveals dysregulation 
of cellular processes including glucose metabolism, protein processing, 
inflammation and oxidative stress, and synaptic signaling. Proteins differentially 
expressed with increasing age in neuroproteomic investigations are included as 
examples. These cellular processes suggest that numerous cell types [microglia 
(green), astrocytes (orange), oligodendrocytes (blue), and neurons (violet)] and 
subcellular components [mitochondria (brown), endoplasmic reticulum (green), 
cytoskeleton (orange/red), and synaptic machinery] are affected by brain aging, and 
may contribute to functional deficits related to the aging hippocampus.
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escape platform in the Morris Water Maze based on surround-
ing contextual cues, or were placed in the maze with no platform 
present to control for exercise and stress in the absence of spatial 
learning. Maze training was performed twice daily for 7 days, and 
all animals were sacrificed immediately following the last trial for 
2DE quantitation of hydrophilic hippocampal proteins. Protein 
spots with significantly different expression between maze-trained 
and control groups were determined to be associated with spatial 
learning. Nearly 80 unique proteins, representing both training-
induced increases and decreases, were identified by MS, and pri-
marily represented metabolic, cytoskeletal, signal transduction, and 
degradation processes. Enolase, actin-interacting, and proteasome/
lysosome subunits were among the subset of proteins increased 
after spatial learning, while numerous proteins related to synap-
tic function including NSF, synapsin 2, dynamin, and the 14-3-3 
isoforms gamma and epsilon, were decreased. An added strength 
of this study is the inclusion of immunoblot confirmations to vali-
date neuroproteomic data (i.e., protein identification and quan-
titation). As the authors point out, many proteins involved in the 
neuronal processes underlying learning and memory were absent 
from this analysis, likely because membrane-associated proteins 
were depleted by the isolation method used, and also because 
these low-abundance proteins fall below the detection threshold 
in traditional neuroproteomic techniques. One unfortunate limita-
tion of this work is that proteins determined to be unchanged by 
spatial training were excluded from identification, which would 
have added to the growing coverage of the rodent hippocampal 
proteome and provided insight regarding proteins not necessarily 
critical for learning and memory.
In a well-designed study of plasticity-induced proteomic 
alterations, McNair et al. (2006) demonstrated both temporal and 
class-specific protein expression pattern changes in ex vivo hip-
pocampal slices prepared from mice aged 4–8 weeks. Plasticity 
was simulated both electrophysiologically, using high-frequency 
stimulation of CA1–CA3 pyramidal cells to induce LTP, and phar-
macologically, using glutamate-induced receptor activation. Both 
acute and chronic alterations in protein expression induced with 
these models of synaptic plasticity were examined by 2-DIGE and 
identified by MS and MS/MS. Four hours following glutamate treat-
ment, long-lasting altered expression of 79 proteins was detected, 
58 of which were sensitive to NMDA receptor blockade. Many of 
these proteins were related to glutamate receptor cycling, cytoskel-
eton regulation, and vesicle trafficking. For example, glutamate 
stimulation downregulated NSF and upregulated actin, which was 
confirmed by two-dimensional immunoblotting. More than 80% 
of hippocampal proteins identified were related to metabolism, 
cytoplasmic organization and biogenesis, and protein transport 
and modification. Electrophysiological LTP induction led to altered 
expression of energy metabolism-related proteins after 10 min, 
and of cytoplasmic organization- and biogenesis-related proteins 
after 240 min. LTP-mediated protein changes included calcineu-
rin, VDAC1, MEK1, growth-associated protein 43, synapsin 2, 
syntaxin 19, and copine 6. Little overlap in proteins with altered 
expression was detected between the 10 and 240 min time points, 
although there were similarities between electrophysiological and 
pharmacological treatment groups. These findings indicate that, in 
interpretation of neuroproteomic datasets in a biological context is 
hindered, ultimately minimizing the impact of the findings. This is 
illustrated by a potentially influential report describing changes in 
protein–protein interactions induced by the formation of spatial 
memory (Nelson et al., 2004). Rats of undescribed strain, sex, and 
age were divided into three training groups (Morris Water Maze 
trained, yoked swim control, and naïve). Following training and 
demonstration of a spatially focused search pattern in the maze-
trained animals, a complex combination of proteomic techniques 
was used to study differential protein interactions. Hippocampal 
protein samples were subjected to affinity-based enrichment of pro-
tein–protein complexes and depletion of non-interacting proteins. 
Identification of interacting proteins significantly regulated with 
spatial learning was performed by separation using 2DE, followed 
by LC–MS analysis. Of the nearly 250 proteins determined to partic-
ipate in binding interactions, 32 were statistically increased in pro-
tein–protein interaction in the trained versus swim control group 
(e.g., stathmin, tropomyosin, tubulin, GFAP, spectrin, F-actin cap-
ping protein B) while eight decreased their interactions (e.g., actin, 
complexin 1). Seven proteins with differential binding between 
swim control and naïve groups were interpreted as indicators of 
water maze-induced stress. The majority of proteins with spatial 
memory-induced interaction alterations were classified as synaptic, 
structural, and signaling proteins. Five of the protein interactions 
determined to be regulated with spatial memory formation and 
for which a protein component was identified were selected for 
pull-down of binding partners. For this work, bait proteins were 
expressed in bacteria for capture of putative interacting proteins 
from hippocampal extracts The captured proteins were identified 
by LC–MS/MS and quantitated by immunoblotting, which demon-
strated the following protein–protein interactions: complexin/p25α 
and complexin/drac1-like protein (decreased with training); CapZ/
tubulin, adenylate kinase/actin, and ATP synthase/14-3-3 gamma 
(increased with training). Interestingly, these changes appeared to 
be specific to the protein–protein interactions themselves, as total 
expression of these individual species was not altered.
This study demonstrates the value of combining traditional 
biochemical and modern proteomic approaches with behavioral 
testing to provide information regarding neuronal protein–pro-
tein interactions that participate in spatial memory formation that 
could not have been obtained without prior knowledge of at least 
one binding partner in these interactions. The report, however, 
is rather technology-driven and lacks information regarding ani-
mal strain, age, sex, and behavioral training/testing, as well as a 
rationale for determining protein–protein interactions in bacteria 
instead of the hippocampal protein samples from these animals. 
Although significant confirmatory and control experiments are 
needed to validate the differential interactions reported with maze 
training in this study, future studies implementing this approach 
may provide further insight into the acute effects of spatial learn-
ing and memory on the hippocampal proteome and on specific 
protein–protein interactions that may affect cognitive function, 
particularly with increasing age.
Using a more traditional proteomic approach, Henninger et al. 
(2007) present a well-designed and highly informative study pair-
ing a spatial learning task with 2DE-based quantitation of cytosolic 
proteins in the rat hippocampus. Forty young-adult male Wistar 
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animals were sacrificed for 2DE-MS/MS analysis of the hippocam-
pal neuroproteome. Surprisingly, of 74 signaling proteins identified, 
15 species were regulated in expression with exercise, and only two 
of these (protein phosphatase 1 and guanine nucleotide-binding 
protein 1) were common to both voluntary and involuntary exercise 
compared to sedentary animals. The 15 differentially expressed 
proteins were represented in either involuntary exercise versus vol-
untary exercise or involuntary exercise versus sedentary rats, indi-
cating a major effect of consistent treadmill running throughout 
adulthood. Interestingly, expression of signaling proteins such as 
PEBP, 14-3-3 zeta, septin 8, and the early endosome fusion protein 
EEA1 was significantly different between voluntarily and involun-
tarily exercising rats, suggesting that voluntary exercise impacts 
processes underlying learning and memory to a greater extent than 
involuntary exercise. In agreement with recent findings that exercise 
improves hippocampus-dependent spatial learning and memory, 
many of the exercise-regulated proteins identified here have been 
associated with cognitive function. Additional work pursuing exer-
cise-mediated regulation of memory associated proteins with aging 
will no doubt increase our understanding of the role of exercise in 
improved cognition throughout the lifespan.
As illustrated by the comparison of voluntary and involuntary 
exercise above, implementation of neuroproteomic approaches in 
behavioral neuroscience research has led to the identification of 
task-dependent regulation of specific proteins. Differential effects 
of spatial learning paradigms have been demonstrated in young-
adult (10–14 weeks) wild-type mice trained in common behavioral 
tests of hippocampus-dependent cognitive function (Zheng et al., 
2009). In the Barnes Maze, mice were trained to locate a dark escape 
chamber hidden below one of 20 holes in a brightly lit circular 
platform based on fixed visual cues. Mice trained in the Multiple 
T-Maze learned to locate a goal box containing a food pellet in a 
maze designed with seven choice points. For both paradigms, yoked 
controls were included to minimize confounding effects of stress 
or food deprivation. Following a probe trial to ensure that trained 
mice had successfully acquired and retained the assigned spatial 
task, hippocampal proteomic composition was evaluated by 2DE 
with nano-LC–MS identification of proteins of interest. Several dif-
ferentially expressed proteins were identified between mice exposed 
to the different training paradigms. Although most of these proteins 
are associated with metabolism and have not been previously linked 
to synaptic mechanisms of learning and memory, several proteins, 
including dual-specificity protein phosphatase 3, calmodulin, and 
NSF, are implicated in synaptic signaling, demonstrating the impor-
tance of synaptic function and maintenance in cognitive function. 
The maze-dependent specificity of proteomic profiles described here 
emphasizes the difficulty of comparing behavioral studies and even 
between identical rodent strains, and the need for careful reporting 
of testing paradigms in neuroproteomic evaluations in cognitive 
neuroscience research. As with age-based neuroproteomic inves-
tigations, comparing studies of the hippocampal neuroproteome 
with models of learning and memory formation is made difficult 
by study-to-study variation in study design. This is particularly true 
with regard to the behavioral testing methods used, potential con-
founding variables such as stress, food deprivation and exercise, and 
the age and species of study subjects.
ex vivo models of hippocampus-dependent learning and memory, 
distinct temporally regulated proteomic alterations are induced. 
These changes may represent neuromolecular processes underlying 
acquisition and retention of spatial memory.
Building on these results, a follow-up study was conducted to 
examine the hippocampal neuroproteome following environmen-
tal enrichment, which has been demonstrated to increase neuronal 
activity and induce spatial learning and memory formation, on the 
hippocampal neuroproteome (McNair et al., 2007). Eight-week 
old male hooded Lister rats were exposed to an open field (non-
enriched) or enriched environment for six weeks, for a final age 
at sacrifice of 14 weeks (i.e., young-adult). The enriched regimen 
included toys, running wheels, and novel objects known to stimulate 
hippocampal plasticity and learning. Neural somata were segregated 
from their distal processes by dissecting CA1 stratum pyramidale 
and stratum radiate to allow examination of somatic and den-
dritic proteomic composition, respectively. Proteomic analyses were 
performed by 2-DIGE and highly sensitive quadrupole MS. Rats 
subjected to environmental enrichment exhibited altered expres-
sion of numerous proteins in both somatic and dendritic samples, 
with both inductions and reductions observed compared to non-
enriched controls. In total, 50 proteins were identified regardless 
of expression, approximately 70% of which are involved in energy 
metabolism, signal transduction, and cytoplasmic organization 
and biogenesis. In stratum pyramidale, environmental enrichment 
increased expression of actin, dynamin, rab7, and proteasome subu-
nits, and decreased expression of protein phosphatase 3, synapsin 
1, PSD95, dynactin, collapsin response mediator protein 2, destrin, 
and ubiquitin. Interestingly, many proteins altered with enrich-
ment were identified as housekeeping gene products, indicating 
that these species may play more complex roles in neuronal func-
tion than traditionally thought. In stratum radiate, exposure to the 
enriched environment was associated with increased phosphoglyc-
erate mutase 1, ATP synthase subunits, VAMP-associated protein 
B, GFAP, and actin, while GFP58, GNBP alpha inhibiting protein 
2, septin 5, cyclin-dependent kinase, and diacylglycerol kinase zeta 
were decreased. This study design did not control for cognitive 
or proteomic effects of increased exercise in rats exposed to the 
enriched environment versus the open field, but it demonstrates 
two important points. First, exposure to environmental enrichment 
alters components of the hippocampal proteome, some of which 
have been previously implicated in learning and memory while 
others are novel. Second, distinct proteomic changes are induced 
in CA1 neuronal processes versus cell bodies, indicating that frac-
tionation approaches are necessary for detecting and differentiating 
these protein expression alterations. Although the findings of this 
study are quite valuable to the cognitive neuroscience field, addi-
tional work examining the effects of environmental manipulation 
and exercise mature adult and aged rats is needed.
Exercise is known to improve neuronal activity and cognitive 
function, and exerts neuroprotective effects in aging hippocampus 
(O’Callaghan et al., 2009; Gomes da Silva et al., 2010; Jedrziewski 
et al., 2010; Voss et al., 2010). The effects of exercise on the hip-
pocampal neuroproteome has been evaluated in a noteworthy study 
of aged male Sprague Dawley rats reported by Chen et al. (2007a). 
Sedentary rats were compared voluntarily (running wheel) and 
involuntarily (treadmill) exercising rats after an 18-month exercise 
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Fischer 344 × Brown Norway rats (Freeman et al., 2009). Adult 
(10 months) and aged (27 months) were assessed for spatial cogni-
tive performance in the Morris Water Maze, and aged animals were 
categorized as cognitively intact (performing similarly to adults) or 
impaired (performing outside the range of adults) prior to sacrifice 
and proteomic assessment. A principal components analysis (PCA) 
of the resulting 2-DIGE expression data revealed that two distinct 
shifts occur in the hippocampal proteome: one with age, which 
accounted for approximately 70% of proteomic variation between 
groups, and one specific to cognitive status. The latter component 
comprised 30% of study variance, and segregated aged cognitively 
impaired animals from both the adult and aged cognitively intact 
groups. In total, nearly 200 hippocampal proteins were confidently 
identified and included a broad range including enzymes and pro-
teasome subunits as well as species implicated in learning and mem-
ory such as protein phosphatase 1E and PEBP. Interestingly, of the 
19 identified proteins regulated with aging (aged versus adult) and 
nine identified proteins regulated specifically with cognitive decline 
(aged impaired versus aged intact) only enolase was common to 
both conditions. Numerous proteins involved in carbohydrate, pro-
tein, coenzyme, and nucleic acid metabolism were regulated with 
age, while regulators of protein quality control such as puromycin-
sensitive aminopeptidase and heat shock proteins were altered with 
cognitive decline. This work identified an age-related dysregula-
tion of multiple enzymes that mediate the ATP-generating steps of 
glycolysis, and more importantly, demonstrated that two distinct 
hippocampal proteomic shifts occur with age-related declines in 
spatial learning and memory that cannot be examined without 
performance-based stratification of aged animals into cognitively 
intact and impaired groups. Additional studies, including a more 
comprehensive range of time points and proteomic fractionation 
techniques, need to be performed to identify whether segregation 
of the hippocampal proteome occurs prior to the development of 
spatial learning and memory impairments, and when cognitive 
deficits and proteomic alterations first manifest.
future work
The work described here has contributed valuable understanding 
of the neuroproteome to the neuroscience and aging fields, and 
marks an important transition from targeted, single molecule stud-
ies to more systems-level evaluations of neuroproteomic profiles. A 
number of excellent reports describing alterations in hippocampal 
protein expression, as assessed by focused study of targets of interest, 
suggest that aging and cognitive decline are associated with altered 
synaptic, metabolic, and signaling functions (Shimohama et al., 
1998; Baxter et al., 1999; Smith et al., 2000; Calabrese et al., 2004; 
Hwang et al., 2006; Nyffeler et al., 2007; Shi et al., 2007; Adams 
et al., 2008; Liu et al., 2008; Canas et al., 2009; Head et al., 2009). 
Neuroproteomic analyses of age-related cognitive decline demon-
strate that brain aging involves dysregulation of metabolism, oxi-
dative stress, protein trafficking, and synaptic function, and that 
many of these processes are also regulated with cognitive decline. 
Additionally, although increasing age is a primary risk factor for 
cognitive decline, the occurrence of cognitive impairment with aging 
is heterogeneous and likely reflects distinct neuroproteomic altera-
tions. Growing evidence suggests that cognitive decline does not 
It is interesting to note that several proteins implicated in 
  hippocampus-dependent learning and memory by neuroprot-
eomic investigations are differentially expressed with aging. For 
example, 14-3-3 signaling proteins, which decrease in expression 
with increasing age (VanGuilder et al., 2010), are regulated at the 
levels of protein content and protein–protein interaction following 
spatial training and exercise (Nelson et al., 2004; Chen et al., 2007a; 
Henninger et al., 2007). Similarly, members of the family of dihy-
dropyrimidinase-related proteins (also known as collapsin response 
mediator proteins) are regulated both with aging (Carrette et al., 
2006; Focking et al., 2006; VanGuilder et al., 2010) and in models 
of learning and memory formation (McNair et al., 2006, 2007; 
Henninger et al., 2007; Zheng et al., 2009). Dihydropyrimidinase-
related proteins contribute to signal transduction and regulation of 
microtubule dynamics and cytoskeletal remodeling (Charrier et al., 
2003; Brittain et al., 2009). Lastly, regulation of protein phosphatases 
and PEBP (also called hippocampal cholinergic neurostimulating 
peptide) has been identified in the aged hippocampal neuropro-
teome (Weinreb et al., 2007; Freeman et al., 2009; VanGuilder et al., 
2010). These proteins have been previously implicated in learning 
and memory, and are among the proteins changed in expression fol-
lowing exercise, environmental enrichment, and training in spatial 
learning tasks (Chen et al., 2007a; McNair et al., 2007; Zheng et al., 
2009), suggesting that age-related dysregulation of these proteins 
may contribute to deficits of spatial learning and memory.
tHe Hippocampal neuroproteome witH age-related 
cognitive decline
An important aspect of age-related cognitive impairment that 
is often overlooked in molecular analyses is the heterogeneity of 
its incidence and severity in both humans and rodent models of 
aging. A number of studies have established that declining spatial 
cognitive function affects a subset of aged individuals, while coun-
terparts matched for age and health status retain cognitive abili-
ties similar to younger adults (Schaie, 1996; Gallagher and Rapp, 
1997; Schonknecht et al., 2005; Freeman et al., 2009; Mungas et 
al., 2010). Investigation of proteins (i.e., the functional products 
of gene transcripts) has been limited to targeted studies of spe-
cific pre-selected proteins or sets of proteins. Although valuable 
to our understanding of the potential functional roles and regula-
tion of these proteins in age-related cognitive decline, larger-scale 
approaches are needed to provide broad quantitative assessment 
of the hippocampal neuroproteome since cognitive decline is a 
complex phenomenon comprising both age-related and cognition-
specific processes that are not entirely understood. Whole-genome 
profiling approaches (e.g., high-density microarrays) investigating 
the effects of aging on cognitive function and hippocampal gene 
expression have identified novel subsets of genes associated with 
declining cognitive performance in aged animals (Blalock et al., 
2003) as well as cognitive decline-specific genes altered between 
aged, cognitively impaired and aged unimpaired rats (Rowe et al., 
2007). Bioinformatic analysis of these large datasets places find-
ings within a biological context of known processes, pathways, and 
functional networks, enabling the identification of dysregulated cel-
lular functions not previously associated with cognitive decline. To 
assess this phenomenon at the neuroproteomic level, we performed 
2-DIGE quantitation and MS/MS identification of unfractionated 
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